Related Experiment Video
Updated: May 18, 2026
10:56
A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
Hereditary conjugated hyperbilirubinaemia: 37 years later
Daniel Dhumeaux1, Serge Erlinger
1University of Paris-Est, Henri-Mondor Hospital, and INSERM U-955, Créteil, France.
Journal of Hepatology
|September 18, 2012
Summary
Rotor syndrome, causing jaundice, is linked to deficiencies in organic anion transporting polypeptides OATP1B1 and OATP1B3. These transporters are crucial for clearing bilirubin and drugs, and their combined deficiency explains Rotor syndrome and potential drug toxicity.
Area of Science:
- Biochemistry
- Genetics
- Hepatology
Background:
- Bilirubin metabolism and excretion are vital liver functions, with disruptions leading to hyperbilirubinemia and jaundice.
- Rotor syndrome, a genetic disorder causing conjugated hyperbilirubinemia, has had an unclear molecular basis.
- Organic anion transporting polypeptides (OATP1B1 and OATP1B3) are key sinusoidal uptake transporters in hepatocytes.
Discussion:
- This study identifies mutations causing simultaneous deficiencies in OATP1B1 and OATP1B3 as the cause of Rotor syndrome.
- A liver-blood shuttle involving sinusoidal export pump Abcc3 and hepatic reuptake by Oatp1a/1b transporters is proposed for bilirubin conjugate clearance.
- This shuttle mechanism may also apply to the detoxification of drug conjugates, preventing hepatocyte injury.
Key Insights:
- Rotor syndrome results from combined OATP1B1 and OATP1B3 deficiencies, impairing hepatic reuptake of bilirubin glucuronide.
- The identified liver-blood shuttle mechanism highlights a novel pathway for detoxification and waste removal.
- Complete OATP1B1 and OATP1B3 deficiencies may significantly increase the risk of adverse drug reactions.
Outlook:
- Further research into the OATP1B1/OATP1B3 shuttle's role in drug metabolism and transport is warranted.
- Genetic screening for OATP1B1 and OATP1B3 mutations could identify individuals at risk for Rotor syndrome and drug toxicity.
- Understanding these transporters is crucial for personalized medicine and optimizing drug therapy.
Related Concept Videos
01:25Jaundice
Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:22Lifecycle of Erythrocytes
Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups.
01:16Hepatic Drug Excretion: Influencing Factors
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...